Atara Biotherapeutics Inc Stock Chart

Atara Biotherapeutics Inc (LSE) · Health Technology. stock live price and technical analysis view. Follow LSE data on Alerta Chart.

Checking data access...

About Atara Biotherapeutics Inc

LSE
Market Cap
$101.20M
Shares Out.
7.02M
Sector
Health Technology
Industry
Pharmaceuticals: Major

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.

www.atarabio.com

Related Markets

Market Hub:Stocks Hub

Need more analysis tools?

With Alerta Chart Pro Terminal, you can follow 4 charts at the same time, see depth (order book) data and set 25 active alerts.

Start for Free
0HIY.GB (0HIY.GB) Stock Live Chart & Technical Analysis | Alerta Chart | Alerta Chart